News and analysis for the global poultry industry.
Industry News & Trends / Egg Processing / Egg Production / North America
on December 20, 2018

Michael Foods enters supply agreement with drug company

Michael Foods will exclusively supply egg protein to Aimmune Therapeutics as it develops investigational new drug to treat egg allergies

Michael Foods has reached an exclusive egg protein supply agreement with Aimmune Therapeutics, a biopharmaceutical company that is developing an investigational new drug (IND) for the treatment of egg allergies.

Aimmune Therapeutics, in a press release dated December 20, announced the submission of its investigational new drug (IND) application…

To view the full article, please register or login.